Quantcast
Home > Quotes > AKER

Akers Biosciences Inc. Common Stock (AKER) Quote & Summary Data

AKER 
$1.72
*  
0.55
24.23%
Get AKER Alerts
*Delayed - data as of Nov. 15, 2018 11:47 ET  -  Find a broker to begin trading AKER now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    AKER Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 1.71 / $ 1.74
1 Year Target
Today's High / Low
$ 2.25 / $ 1.50
Share Volume
595,798
50 Day Avg. Daily Volume
649,323
Previous Close
$ 2.27
52 Week High / Low
$ 7.8424 / $ 0.976
Market Cap
20,232,854
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.59

Special Dividend Data

Special Dividend
N/A
Special Dividend Date
Nov. 8, 2018
Special Dividend Payment Date
N/A

Intraday Chart

Shares Traded

Share Volume:
595,798
50 Day Avg. Daily Volume:
649,323

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
Earnings Per Share (EPS):
$ -3.28

Trading Range

The current last sale of $1.72 is 76.23% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 2.25 $ 7.8424
 Low: $ 1.50 $ 0.976

Company Description (as filed with the SEC)

Akers Biosciences, Inc. ("Akers," "we" or the "Company") develops, manufactures, and supplies rapid, point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician in a time- and cost-efficient manner. Akers believes it has advanced the science of diagnostics through the development of several innovative proprietary platform technologies that provide product development flexibility. All of Akers' rapid, single-use tests are performed in vitro (outside the body) and are designed to enhance patient well-being and reduce total outcome costs of healthcare. The Company's current product offerings and pipeline products focus on delivering diagnostic assistance in a wide variety of healthcare fields/specialties, including cardiology/emergency medicine, metabolism/nutrition, diabetes, respiratory disease and infectious disease detection, as well as for on and off-the-job alcohol safety initiatives.  ... More ...  

Nasdaq Official Price

Open Price:
$ 2.25
Open Date:
Nov. 15, 2018
Close Price:
N/A
Close Date:
N/A

Research Brokers before you trade

Want to trade FX?

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x